Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing reduced-intensity allogeneic hematopoietic cell transplantation
- PMID: 40803426
- DOI: 10.1016/j.jtct.2025.08.007
Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing reduced-intensity allogeneic hematopoietic cell transplantation
LinkOut - more resources
Full Text Sources